
Bristol-Myers Squibb Company Ce
Share · US1101221406 · CELG-RI (XNYS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | - | - | - |
Company Profile for Bristol-Myers Squibb Company Ce Share
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Company Data
Name Bristol-Myers Squibb Company Ce
Company Bristol-Myers Squibb Company Ce
Symbol CELG-RI
Website
http://www.bms.com
Primary Exchange
NYSE

ISIN US1101221406
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
Market Capitalization 84 Mrd.
Country United States of America
Currency USD
Employees 34,1 T
Address , Princeton
Ticker Symbols
Name | Symbol |
---|---|
NYSE | CELG-RI |
More Shares
Investors who hold Bristol-Myers Squibb Company Ce also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.